Skip to main content
OpenTrials

Clinical trial condition

Gliosarcoma

Explore clinical trials studying Gliosarcoma. Study availability and eligibility vary by location and protocol.

373 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Gliosarcoma trial results

Completed

Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme

NCT00086879

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • U.Z. Gasthuisberg Leuven, Belgium
  • Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France
  • Centre Regional Rene Gauducheau Nantes-Saint Herblain, France
  • Centre Antoine Lacassagne Nice, France
View Trial Details
Completed

Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00047294

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Cancer Center at the University of Virginia Charlottesville, Virginia, United States
View Trial Details
Completed

Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma

NCT00823797

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +22 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

NCT01026493

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +18 more
Locations
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Cancer Research Center of Hawaii Honolulu, Hawaii, United States
  • Queen's Cancer Institute at Queen's Medical Center Honolulu, Hawaii, United States
View all 17 locations
View Trial Details
Completed

Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma

NCT00379080

Conditions
Adult Brain Tumor, Adult Giant Cell Glioblastoma, Adult Glioblastoma, +20 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Completed

Pazopanib in Treating Patients With Recurrent Glioblastoma

NCT00459381

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions